Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, Nov. 15 '25)

Image
By G.M.

 


    Int J Infect Dis

  1. SILVA CAC, Bomfim AP, Medeiros JD, Silva JJ, et al
    Nasal Microbiota and Clinical Features in Acute Flu-Like Illness: COVID-19 Status and Long COVID Follow-Up.
    Int J Infect Dis. 2025 Nov 11:108196. doi: 10.1016/j.ijid.2025.108196.
    PubMed         Abstract available

  2. SONG J, Jeong S, Chun AY, Jung J, et al
    Incidence of Respiratory Infections after the COVID-19 Pandemic (2023-2024) and Its Association of Vaccination Among Entire Populations in Korea.
    Int J Infect Dis. 2025 Nov 7:108194. doi: 10.1016/j.ijid.2025.108194.
    PubMed         Abstract available

  3. VERGORI A, Matusali G, Lepri AC, Cimini E, et al
    Supporting equitable booster strategies: one-year real-world immunogenicity data in people with HIV (PWH) receiving different variant-adapted COVID-19 vaccines.
    Int J Infect Dis. 2025 Nov 7:108189. doi: 10.1016/j.ijid.2025.108189.
    PubMed         Abstract available


    J Infect

  4. CRAWFORD-JONES D, Charlett M, Downs L, Jeffery K, et al
    Real-world utility of antigen-based testing (LumiraDX) for SARS-CoV-2 and influenza A/B in an acute hospital emergency care setting: a useful triage tool.
    J Infect. 2025;91:106649.
    PubMed        


    J Med Virol

  5. LI J, Wang X, Li J, Chen Y, et al
    Antigenic Imprinting and Immune Response Dynamics: Neutralization Against Emerging SARS-CoV-2 Omicron Variants Following Breakthrough Infections.
    J Med Virol. 2025;97:e70681.
    PubMed         Abstract available

  6. WOLF JM, Pille A, Kunde L, de Souza MCF, et al
    COVID-19 and the Prediction of 30-Day Hospital Readmissions: A Brazilian Retrospective Cohort Study Applying the Hospital Score Before and After the Pandemic.
    J Med Virol. 2025;97:e70693.
    PubMed         Abstract available


    J Virol

  7. MUTHURAMAN K, Jackman M, Liang Y, Garrett ME, et al
    Human antibody targeting of coronavirus spike S2 subunit is associated with protection mediated by Fc effector functions.
    J Virol. 2025 Nov 12:e0152325. doi: 10.1128/jvi.01523.
    PubMed         Abstract available


    JAMA

  8. FRIEDEN TR, Schaffner W, Sharfstein JM
    CDC's Failure to Recommend COVID-19 Vaccination-"Shared Clinical Decision-Making" Is Abdication of Responsibility.
    JAMA. 2025 Nov 13. doi: 10.1001/jama.2025.22473.
    PubMed        


    Science

  9. MERVIS J
    Sweeping ban on Chinese collaborations proposed.
    Science. 2025;390:662-663.
    PubMed         Abstract available

  10. COHEN J
    The pandemic next time.
    Science. 2025;390:667-671.
    PubMed         Abstract available


    Travel Med Infect Dis

  11. CHAO HY, Chang CJ, Lai TJ, Tsai JS, et al
    Loneliness in Long-term Taiwanese Expatriates and Domestic Residents in the COVID-19 Era: A Cross-sectional Study.
    Travel Med Infect Dis. 2025 Nov 5:102928. doi: 10.1016/j.tmaid.2025.102928.
    PubMed         Abstract available


    Zhonghua Jie He He Hu Xi Za Zhi

  12. HE XY, Li XH, Tong ZH
    [Cognitive impairment in long COVID: advances in pathological mechanisms and exercise rehabilitation interventions].
    Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:1087-1095.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »